Clinical Trials Browser

Pituitary Neoplasms, Prolactinoma

NCT06936813 2026-01-08

The PROMISE Survey

Active not recruiting

530 enrolled

Endocrine

Pituitary Neoplasms, Prolactinoma

NCT04106531 2025-12-05

Prolac-10

Terminated

8 enrolled

Endocrine

Pituitary Neoplasms, Prolactinoma

NCT05236829 2024-05-24

Exercise Capacity and Physical Activity Level in Prolactinoma Patients

Completed

38 enrolled

Motor Activity, Prolactinoma

NCT01504399 2018-08-22

Rhinological Outcomes in Endonasal Pituitary Surgery

Completed

235 enrolled

Endocrine

Acromegaly, Adrenocortical Hyperfunction, Pituitary Neoplasms, Prolactinoma

NCT02536261 2017-05-16

Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus

Unknown

30 enrolled

Prolactinoma

NCT02854228 2016-08-03

PITUICARE-Lyon

Unknown

1,300 enrolled

Endocrine

Acromegaly, Pituitary Neoplasms, Prolactinoma

NCT00598949 2010-12-15

Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma

Unknown

600 enrolled

Endocrine

Acromegaly, Adenoma, Neoplasms, Pituitary Diseases, Pituitary Neoplasms, Prolactinoma

NCT00460616 2008-04-16

ValveCab

Completed

50 enrolled

Heart Valve Diseases, Prolactinoma

NCT00481299 2007-06-01

Insulin Resistance in Women With Prolactinoma

Completed

2,004 enrolled

Hyperlipidemias, Hyperprolactinemia, Insulin Resistance, Prolactinoma

Clinical Trials

OEMacroPrL

The PROMISE Survey

Prolac-10

Exercise Capacity and Physical Activity Level in Prolactinoma Patients

Rhinological Outcomes in Endonasal Pituitary Surgery

Dopamine Agonists Withdrawal Study of Invasive Prolactinomas Involving the Cavernous Sinus

PITUICARE-Lyon

Prevalence of Pituitary Incidentaloma in Relatives of Patients With Pituitary Adenoma

ValveCab

Insulin Resistance in Women With Prolactinoma